120 related articles for article (PubMed ID: 11585639)
1. Upregulation of the inhibitor of apoptosis proteins in activated T lymphocytes from patients with multiple sclerosis.
Sharief MK; Semra YK
J Neuroimmunol; 2001 Oct; 119(2):350-7. PubMed ID: 11585639
[TBL] [Abstract][Full Text] [Related]
2. Heightened expression of survivin in activated T lymphocytes from patients with multiple sclerosis.
Sharief MK; Semra YK
J Neuroimmunol; 2001 Oct; 119(2):358-64. PubMed ID: 11585640
[TBL] [Abstract][Full Text] [Related]
3. Disease activity in multiple sclerosis correlates with T lymphocyte expression of the inhibitor of apoptosis proteins.
Semra YK; Seidi OA; Sharief MK
J Neuroimmunol; 2002 Jan; 122(1-2):159-66. PubMed ID: 11777555
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of the inhibitor of apoptosis proteins in T cells from patients with multiple sclerosis following interferon-beta therapy.
Sharief MK; Noori MA; Zoukos Y
J Neuroimmunol; 2002 Aug; 129(1-2):224-31. PubMed ID: 12161039
[TBL] [Abstract][Full Text] [Related]
5. Upregulated survivin expression in activated T lymphocytes correlates with disease activity in multiple sclerosis.
Sharief MK; Noori MA; Douglas MR; Semra YK
Eur J Neurol; 2002 Sep; 9(5):503-10. PubMed ID: 12220382
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis.
Semra YK; Seidi OA; Sharief MK
J Neuroimmunol; 2001 Feb; 113(2):268-74. PubMed ID: 11164911
[TBL] [Abstract][Full Text] [Related]
7. The expression of pro- and anti-apoptosis Bcl-2 family proteins in lymphocytes from patients with multiple sclerosis.
Sharief MK; Douglas M; Noori M; Semra YK
J Neuroimmunol; 2002 Apr; 125(1-2):155-62. PubMed ID: 11960652
[TBL] [Abstract][Full Text] [Related]
8. The expression of apoptosis-regulatory proteins in B lymphocytes from patients with multiple sclerosis.
Seidi OA; Sharief MK
J Neuroimmunol; 2002 Sep; 130(1-2):202-10. PubMed ID: 12225903
[TBL] [Abstract][Full Text] [Related]
9. Expression ratios of the Bcl-2 family proteins and disease activity in multiple sclerosis.
Sharief MK; Matthews H; Noori MA
J Neuroimmunol; 2003 Jan; 134(1-2):158-65. PubMed ID: 12507784
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of survivin expression in T lymphocytes after interferon beta-1a treatment in patients with multiple sclerosis.
Sharief MK; Semra YK
Arch Neurol; 2002 Jul; 59(7):1115-21. PubMed ID: 12117359
[TBL] [Abstract][Full Text] [Related]
11. Impaired Fas-independent apoptosis of T lymphocytes in patients with multiple sclerosis.
Sharief MK
J Neuroimmunol; 2000 Sep; 109(2):236-43. PubMed ID: 10996226
[TBL] [Abstract][Full Text] [Related]
12. Increased cellular expression of the caspase inhibitor FLIP in intrathecal lymphocytes from patients with multiple sclerosis.
Sharief MK
J Neuroimmunol; 2000 Nov; 111(1-2):203-9. PubMed ID: 11063839
[TBL] [Abstract][Full Text] [Related]
13. Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination.
Hebb AL; Moore CS; Bhan V; Campbell T; Fisk JD; Robertson HA; Thorne M; Lacasse E; Holcik M; Gillard J; Crocker SJ; Robertson GS
Mult Scler; 2008 Jun; 14(5):577-94. PubMed ID: 18566024
[TBL] [Abstract][Full Text] [Related]
14. Activation-induced cell death in T lymphocytes from multiple sclerosis patients.
Moreno M; Negrotto L; Río J; Moubarak R; Martín I; Bustamante MF; Comella JX; Vidal-Jordana A; Pérez-Boza J; Montalban X; Comabella M
J Neuroimmunol; 2014 Jul; 272(1-2):51-5. PubMed ID: 24793898
[TBL] [Abstract][Full Text] [Related]
15. Inhibitor of apoptosis protein (IAP) profiling in experimental autoimmune encephalomyelitis (EAE) implicates increased XIAP in T lymphocytes.
Moore CS; Hebb AL; Robertson GS
J Neuroimmunol; 2008 Jan; 193(1-2):94-105. PubMed ID: 18055022
[TBL] [Abstract][Full Text] [Related]
16. Theileria parva-transformed T cells show enhanced resistance to Fas/Fas ligand-induced apoptosis.
Küenzi P; Schneider P; Dobbelaere DA
J Immunol; 2003 Aug; 171(3):1224-31. PubMed ID: 12874209
[TBL] [Abstract][Full Text] [Related]
17. Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis.
Cipriani P; Fulminis A; Pingiotti E; Marrelli A; Liakouli V; Perricone R; Pignone A; Matucci-Cerinic M; Giacomelli R
J Rheumatol; 2006 Oct; 33(10):2003-14. PubMed ID: 17014016
[TBL] [Abstract][Full Text] [Related]
18. Interferon-beta therapy downregulates the anti-apoptosis protein FLIP in T cells from patients with multiple sclerosis.
Sharief MK; Semra YK; Seidi OA; Zoukos Y
J Neuroimmunol; 2001 Nov; 120(1-2):199-207. PubMed ID: 11694335
[TBL] [Abstract][Full Text] [Related]
19. Increased Fas antigen on T cells in multiple sclerosis.
Ichikawa H; Ota K; Iwata M
J Neuroimmunol; 1996 Dec; 71(1-2):125-9. PubMed ID: 8982111
[TBL] [Abstract][Full Text] [Related]
20. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.
Strauss G; Knape I; Melzner I; Debatin KM
J Immunol; 2003 Aug; 171(3):1172-82. PubMed ID: 12874203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
